HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Martin Canis Selected Research

Etanercept (Enbrel)

1/2016Tumor Necrosis Factor-induced Decrease of Cochlear Blood Flow Can Be Reversed by Etanercept or JTE-013.
11/2014Application of a TNF-alpha-inhibitor into the scala tympany after cochlear electrode insertion trauma in guinea pigs: preliminary audiologic results.
8/2013TNF-α inhibition using etanercept prevents noise-induced hearing loss by improvement of cochlear blood flow in vivo.
11/2010Tumor necrosis factor-α enhances microvascular tone and reduces blood flow in the cochlea via enhanced sphingosine-1-phosphate signaling.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Martin Canis Research Topics

Disease

27Neoplasms (Cancer)
03/2022 - 02/2009
26Squamous Cell Carcinoma of Head and Neck
05/2022 - 08/2013
8Hearing Loss (Hearing Impairment)
10/2022 - 12/2009
8Carcinoma (Carcinomatosis)
10/2020 - 02/2009
7Head and Neck Neoplasms (Head and Neck Cancer)
03/2022 - 01/2015
7Squamous Cell Carcinoma (Epidermoid Carcinoma)
10/2020 - 07/2012
6Neoplasm Metastasis (Metastasis)
05/2022 - 07/2012
4Inflammation (Inflammations)
03/2022 - 01/2012
4Wounds and Injuries (Trauma)
11/2019 - 07/2010
3Meniere Disease (Menieres Disease)
03/2021 - 10/2014
3Laryngeal Neoplasms (Laryngeal Cancer)
01/2017 - 09/2013
3Sensorineural Hearing Loss
12/2014 - 06/2007
2Mixed Conductive-Sensorineural Hearing Loss
10/2022 - 12/2021
2Hypoxia (Hypoxemia)
03/2022 - 10/2021
2Nasal Polyps (Nasal Polyp)
07/2021 - 01/2013
2Lymphatic Metastasis
01/2021 - 10/2020
2Mouth Neoplasms (Oral Cancer)
10/2019 - 10/2017
2Hypopharyngeal Neoplasms
01/2017 - 03/2014
2Tinnitus
01/2011 - 06/2007
2Sudden Hearing Loss (Sudden Deafness)
11/2010 - 12/2009
1Residual Neoplasm
01/2022
1Asthma (Bronchial Asthma)
07/2021
1Breast Neoplasms (Breast Cancer)
01/2021
1Otosclerosis
01/2021
1Hypertrophy
04/2020
1Colorectal Neoplasms (Colorectal Cancer)
01/2020
1Cognitive Dysfunction
12/2019
1Alzheimer Disease (Alzheimer's Disease)
12/2019
1Oropharyngeal Neoplasms
01/2019
1Anemia
01/2018

Drug/Important Bio-Agent (IBA)

5Proteins (Proteins, Gene)FDA Link
01/2022 - 01/2012
5Epithelial Cell Adhesion MoleculeIBA
01/2021 - 02/2009
4Biomarkers (Surrogate Marker)IBA
01/2022 - 06/2021
4DNA (Deoxyribonucleic Acid)IBA
01/2022 - 07/2015
4Pharmaceutical PreparationsIBA
01/2017 - 01/2013
4Etanercept (Enbrel)FDA Link
01/2016 - 11/2010
3Fibrinogen (Factor I)FDA Link
01/2017 - 12/2009
3Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA
11/2014 - 11/2010
2RNA (Ribonucleic Acid)IBA
03/2022 - 10/2021
2Moxifloxacin (Avelox)FDA Link
01/2021 - 01/2020
2Ophthalmic Solutions (Eye Drops)IBA
01/2021 - 01/2020
2VimentinIBA
10/2018 - 01/2018
2Cadherins (E-Cadherin)IBA
01/2018 - 01/2018
2CytokinesIBA
01/2018 - 01/2012
2Cyclin-Dependent Kinase Inhibitor p16IBA
01/2016 - 07/2015
2Histamine (Histamine Dihydrochloride)FDA Link
01/2015 - 10/2014
2Betahistine (Serc)IBA
01/2015 - 10/2014
2Hydroxyethyl Starch Derivatives (Pentastarch)FDA Link
02/2013 - 01/2012
2AerosolsIBA
01/2013 - 11/2010
2oxidized low density lipoproteinIBA
06/2012 - 12/2009
2CholesterolIBA
01/2011 - 06/2007
2Oxidoreductases (Dehydrogenase)IBA
01/2011 - 06/2007
2AllergensIBA
01/2011 - 05/2010
2Coenzyme A (CoA)IBA
01/2011 - 06/2007
1Biological ProductsIBA
12/2021
1Chemokine ReceptorsIBA
12/2021
1ProteomeIBA
10/2021
1Small Cytoplasmic RNAIBA
10/2021
1lipopolysaccharide AIBA
10/2021
1EndotoxinsIBA
10/2021
1AntibodiesIBA
07/2021
1Lidocaine (Xylocaine)FDA LinkGeneric
03/2021
1Plasminogen Activators (Plasminogen Activator)IBA
01/2021
1Mitogen-Activated Protein KinasesIBA
01/2021
1Urokinase-Type Plasminogen Activator (Urokinase)FDA Link
01/2021
1VLDL LipoproteinsIBA
01/2021
1NeurotoxinsIBA
04/2020
1Neoplasm Antigens (Tumor Antigens)IBA
01/2020
11,4- bis(4'- hydroxystyryl)- 2- methoxybenzeneIBA
12/2019
1BSC4090IBA
12/2019
1Oxygen (Dioxygen)IBA
11/2019
1MicroRNAs (MicroRNA)IBA
10/2019
1Epidermal Growth Factor (EGF)IBA
01/2018
1Hemoglobins (Hemoglobin)IBA
01/2018
1LigandsIBA
01/2018
1Intercellular Signaling Peptides and Proteins (Growth Factors)IBA
01/2018
1Ancrod (Arvin)IBA
01/2017
1Adrenal Cortex Hormones (Corticosteroids)IBA
01/2017
1Formaldehyde (Formol)FDA Link
01/2016
1JTE 013IBA
01/2016
1CXCR4 Receptors (CXCR4 Receptor)IBA
01/2016

Therapy/Procedure

16Therapeutics
03/2022 - 06/2012
15Lasers (Laser)
10/2020 - 03/2013
11Radiotherapy
03/2022 - 06/2014
9Neck Dissection (Radical Neck Dissection)
05/2022 - 07/2012
3Ossicular Prosthesis (TORP)
10/2022 - 12/2014
3Aftercare (After-Treatment)
08/2019 - 01/2011
3Free Tissue Flaps
10/2017 - 09/2013
3Chemoradiotherapy
10/2016 - 07/2015
2Hearing Aids (Hearing Aid)
10/2022 - 12/2014
2Combined Modality Therapy
01/2019 - 01/2017
2Laryngectomy
01/2017 - 03/2014
2Laser Therapy (Surgery, Laser)
03/2013 - 07/2012
2Blood Component Removal (Apheresis)
06/2012 - 12/2009
1Immunotherapy
12/2021
1Biological Therapy
07/2021
1Stapes Surgery (Stapedectomy)
01/2021
1Blood Transfusion (Blood Transfusions)
01/2018
1Surgical Flaps
10/2017
1Palliative Care (Palliative Therapy)
01/2016